================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------- FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 TITAN PHARMACEUTICALS, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 94-3171940 - ------------------------ -------------------------- (State of incorporation (I.R.S. employee or organization) identification no.) 400 Oyster Point Boulevard, Suite 505, South San Francisco, California 94080 - -------------------------------------------------------------------------------- (Address of principal executive offices) (zip code) If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A(c), please check the following box [x] If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A(d), please check the following box [_] Securities Act registration statement file number to which this form relates: ______________________ (If applicable) Securities to be registered pursuant to Section 12(b) of the Act: Title of Each Class Name of Each Exchange on Which to be so Registered Each class is to be Registered - ------------------- ------------------------------ Common Stock, $.001 par value American Stock Exchange Redeemable Class A Warrants American Stock Exchange Securities to be registered pursuant to Section 12(g) of the Act: None 2 INFORMATION REQUIRED IN REGISTRATION STATEMENT ITEM 1. DESCRIPTION OF REGISTRANTS'S SECURITIES TO BE REGISTERED. The Information called for by this Item 1 is incorporated herein by reference from the Registrant's Registration Statement on Form S-1 (File No. 33-99386) filed with the Securities and Exchange Commission. ITEM 2. EXHIBITS None. SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. Date: November 11, 1998 TITAN PHARMACEUTICALS, INC. By: /s/ ROBERT E. FARRELL ----------------------------------------- Robert E. Farrell Executive Vice President and Chief Financial Officer 3